Identification of Small Molecule Inhibitors of Tau Aggregation by Targeting Monomeric Tau As a Potential Therapeutic Approach for Tauopathies

Documenti analoghi

• Extracellular Monomeric Tau Protein Is Sufficient to Initiate the Spread of Tau Protein Pathology
  di: Michel, Claire H., et al.
  Pubblicazione: (2014)
• Identification of small-molecule binding pockets in the soluble monomeric form of the Aβ42 peptide
  di: Zhu, Maximillian, et al.
  Pubblicazione: (2013)
• Suppressing Tau Aggregation and Toxicity by an Anti-Aggregant Tau Fragment
  di: Pir, Ghulam Jeelani, et al.
  Pubblicazione: (2018)
• Are Tau Aggregates Toxic or Protective in Tauopathies?
  di: Cowan, Catherine M., et al.
  Pubblicazione: (2013)
• Tau mutant A152T, a risk factor for FTD/PSP, induces neuronal dysfunction and reduced lifespan independently of aggregation in a C. elegans Tauopathy model
  di: Pir, Ghulam Jeelani, et al.
  Pubblicazione: (2016)